Integrated genomic, immunoinformatic and experimental evaluation of conserved pneumococcal surface proteins for serotype-independent vaccine development.
PsaA is the most promising serotype-independent vaccine candidate, while other AdcA, AmiA, and Lmb represent potential antigens for multicomponent formulations.